Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Neil A. Hoye"'
Autor:
Neil A. Hoye, Luke C. Wilson, Gerard T. Wilkins, David L. Jardine, Tracey L. Putt, Ari Samaranayaka, John B.W. Schollum, Robert J. Walker
Publikováno v:
Kidney International Reports, Vol 2, Iss 5, Pp 856-865 (2017)
Sympathetic neural activation is markedly increased in end-stage kidney disease (ESKD). Catheter-based renal denervation (RDN) reduces sympathetic overactivity and blood pressure in resistant hypertension. We investigated the effect of RDN on sympath
Externí odkaz:
https://doaj.org/article/f1c5d6f2540541468a0c142c4b5823a5
Publikováno v:
Seminars in Dialysis. 32:255-265
Cardiovascular morbidity and mortality remain frustratingly common in dialysis patients. A dearth of established evidence-based treatment calls for alternative therapeutic avenues to be embraced. Sympathetic hyperactivity, predominantly due to affere
Publikováno v:
Journal of Interventional Cardiac Electrophysiology. 51:51-59
Atrial fibrillation (AF) commonly occurs in chronic kidney disease (CKD), occasioning adverse outcomes. Merging pulmonary vein isolation (PVI) and renal sympathetic denervation (RSD) may decrease the recurrence of AF in subjects with CKD and uncontro
Autor:
Tracey L. Putt, Gerard T. Wilkins, David L. Jardine, Robert J. Walker, Ari Samaranayaka, John B. W. Schollum, Luke C. Wilson, Neil A. Hoye
Publikováno v:
Kidney International Reports, Vol 2, Iss 5, Pp 856-865 (2017)
Kidney International Reports
Kidney International Reports
Introduction Sympathetic neural activation is markedly increased in end-stage kidney disease (ESKD). Catheter-based renal denervation (RDN) reduces sympathetic overactivity and blood pressure in resistant hypertension. We investigated the effect of R
Publikováno v:
IJC Metabolic & Endocrine. 15:6-9
Introduction Recent studies have shown that in chronic kidney disease (CKD) 25(OH)D deficiency or insufficiency are a significant risk factor for cardiovascular diseases, sudden cardiac death and mortality. The high incidence of premature ventricular
Publikováno v:
IJC Metabolic & Endocrine. 14:29-32
Autor:
Neil Alexander Hoye, Luis Marcelo Rodrigues Paz, Márcio Galindo Kiuchi, Gustavo Ramalho e Silva, Gladyston Luiz Lima Souto, Shaojie Chen
Publikováno v:
IJC Metabolic & Endocrine. 14:53-58
Introduction Recent studies have shown that in chronic kidney disease (CKD) 25(OH)D deficiency or insufficiency is a significant risk factor for cardiovascular diseases (CVDs), sudden cardiac death (SCD) and mortality. Premature ventricular complexes
Publikováno v:
Kidney Research and Clinical Practice
Kidney Research and Clinical Practice, Vol 36, Iss 3, Pp 264-273 (2017)
Kidney Research and Clinical Practice, Vol 36, Iss 3, Pp 264-273 (2017)
Background Atrial fibrillation (AF) is highly common, and is most frequently observed in individuals with hypertension and structural cardiac disease. Sympathetic hyperactivity plays a fundamental role in the progression, maintenance and aggravation
Autor:
James C. Baldi, Catherine Sheat, Michael J.A. Williams, Patrick J. Manning, Gerard T. Wilkins, Luke C. Wilson, Genevieve A. Wilson, Karen C. Peebles, Neil A. Hoye
Publikováno v:
Physiological Reports
People with type 1 diabetes (T1D) have lower exercise capacity (V̇O2max) than their age‐matched nondiabetic counterparts (CON), which might be related to cardiac autonomic dysfunction. We examined whether Heart Rate Variability (HRV; indicator of
Autor:
Neil Alexander Hoye, Ary Getulio de Paula Filho, Márcio Galindo Kiuchi, Gustavo Ramalho e Silva, Tetsuaki Kiuchi, Luis Marcelo Rodrigues Paz, Gladyston Luiz Lima Souto, Shaojie Chen
Publikováno v:
Journal of Advanced Therapies and Medical Innovation Sciences. 2
Aim: The aim of this prospective observational non-inferiority study was to compare the capacity for control of essential hypertension between renal sympathetic denervation (RSD) and either angiotensin-converting enzyme inhibitors (ACEI) or angiotens